AB
AURA icon

Amalgamated Bank’s Aura Biosciences AURA Stock Holding History

Amalgamated Bank’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,380
Closed -$8K – 1729
2025
Q4 		$8K Sell
1,380
-221
-14% -$1.31K ﹤0.01% 2498
2025
Q3 		$10K Hold
1,601
– – ﹤0.01% 2450
2025
Q2 		$10K Hold
1,601
– – ﹤0.01% 2421
2025
Q1 		$9K Buy
1,601
+388
+32% +$2.94K ﹤0.01% 2400
2024
Q4 		$10K Hold
1,213
– – ﹤0.01% 2417
2024
Q3 		$11K Hold
1,213
– – ﹤0.01% 2385
2024
Q2 		$9K Hold
1,213
– – ﹤0.01% 2484
2024
Q1 		$10K Sell
1,213
-893
-42% -$7.4K ﹤0.01% 2422
2023
Q4 		$19K Sell
2,106
-189
-8% -$1.6K ﹤0.01% 2663
2023
Q3 		$21K Hold
2,295
– – ﹤0.01% 2624
2023
Q2 		$28K Sell
2,295
-766
-25% -$8.19K ﹤0.01% 2562
2023
Q1 		$28K Buy
3,061
+120
+4% +$1.25K ﹤0.01% 2515
2022
Q4 		$31K Hold
2,941
– – ﹤0.01% 2610
2022
Q3 		$53K Buy
2,941
+45
+2% +$681 ﹤0.01% 2429
2022
Q2 		$41K Buy
2,896
+2,105
+266% +$34.8K ﹤0.01% 2572
2022
Q1 		$17K Buy
+791
New +$15.1K ﹤0.01% 2844

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Amalgamated Bank's AURA Position: Q1 2026 in Review

Amalgamated Bank sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 1,380 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in AURA in Q1 2022 and held it in 16 quarters. The position peaked at $53K in Q3 2022. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Amalgamated Bank reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,380 Aura Biosciences shares in Q1 2026, an estimated $8K.
  • Amalgamated Bank first reported a position in Aura Biosciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Aura Biosciences position peaked at $53K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.